Skip to main content
Clinical Trials/NCT04771065
NCT04771065
Unknown
Not Applicable

Microendoscopic Transventricular Deep Brain Stimulation of the Anterior Nucleus of the Thalamus as a Safe and Efficient Treatment in Intractable Epilepsy

University Hospital, Montpellier1 site in 1 country10 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Refractory Epilepsy
Sponsor
University Hospital, Montpellier
Enrollment
10
Locations
1
Primary Endpoint
Absence of hemorraghic complication
Last Updated
5 years ago

Overview

Brief Summary

Deep Brain Stimulation (DBS) of the anterior nucleus of the thalamus (ANT) has been proposed in patients with severe intractable epilepsy. When used, the transventricular approach increases the risk of bleeding due the anatomy around the entry point in the thalamus. To avoid such a complication, the investigators used a transventricular microendoscopic technique.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 29, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Absence of hemorraghic complication

Time Frame: 1 day

Absence of hemorraghic complication on post operative MRI

Secondary Outcomes

  • responder rate(5 years)

Study Sites (1)

Loading locations...

Similar Trials